151 related articles for article (PubMed ID: 38156603)
1. Human papilloma virus (HPV) vaccine and cervical cancer prevention in Africa.
Okonofua F; Edouard L; Isikhuemen M
Afr J Reprod Health; 2023 Dec; 27(12):9-14. PubMed ID: 38156603
[TBL] [Abstract][Full Text] [Related]
2. Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.
Agimas MC; Adugna DG; Derseh NM; Kassaw A; Kassie YT; Abate HK; Mekonnen CK
BMC Public Health; 2024 Mar; 24(1):842. PubMed ID: 38500046
[TBL] [Abstract][Full Text] [Related]
3. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
4. Knowledge and Attitudes of Women towards Human Papilloma Virus and HPV Vaccine in Thulamela Municipality of Vhembe District in Limpopo Province, South Africa.
Ramathuba DU; Ngambi D
Afr J Reprod Health; 2018 Sep; 22(3):111-119. PubMed ID: 30381938
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Vaccine: The Cancer Prevention Moonshot.
Petrie K; Wells A; Eckert LO
Obstet Gynecol Clin North Am; 2023 Jun; 50(2):339-348. PubMed ID: 37149314
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N
Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200
[TBL] [Abstract][Full Text] [Related]
7. Introducing human papillomavirus vaccines into the health system in South Africa.
Botha MH; Dochez C
Vaccine; 2012 Sep; 30 Suppl 3():C28-34. PubMed ID: 22939017
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
[TBL] [Abstract][Full Text] [Related]
9. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda.
Honnavar P; Mansoor E; Tulloch C; Udayan U; Cosmello I; Patel P; Bersma A
Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512042
[No Abstract] [Full Text] [Related]
11. The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa.
Snyman LC; Dreyer G; Botha MH; van der Merwe FH; Becker PJ
S Afr Med J; 2015 Jan; 105(2):115-20. PubMed ID: 26242529
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.
Li X; Stander MP; Van Kriekinge G; Demarteau N
BMC Infect Dis; 2015 Dec; 15():566. PubMed ID: 26652918
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa.
Russell VL; Ogilvie G; Beksinska M; Nyrenda M; Mitchell-Foster S; Lavoie J; Harder H; Wood B; Smith P; Dietrich JJ; Smit J; Brockman MA; Gray G; Kaida On Behalf Of The Ayazazi Research Team A
S Afr Med J; 2020 Aug; 110(9):887-893. PubMed ID: 32880274
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.
Obeid DA; Almatrrouk SA; Alfageeh MB; Al-Ahdal MNA; Alhamlan FS
J Infect Public Health; 2020 Sep; 13(9):1304-1313. PubMed ID: 32564935
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
[TBL] [Abstract][Full Text] [Related]
16. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
17. Role of human papillomavirus (HPV) in cancers.
Khan A
S Afr Med J; 2023 Oct; 113(10):10. PubMed ID: 37881906
[No Abstract] [Full Text] [Related]
18. Human papilloma virus vaccines: need to be introduced in India.
Verma R; Khanna P
Hum Vaccin Immunother; 2013 Jan; 9(1):97-9. PubMed ID: 23108360
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
Front Public Health; 2022; 10():799984. PubMed ID: 35174123
[TBL] [Abstract][Full Text] [Related]
20. Human papilloma viruses and cancer in the post-vaccine era.
Galani E; Christodoulou C
Clin Microbiol Infect; 2009 Nov; 15(11):977-81. PubMed ID: 19874381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
